Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121626454> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2121626454 abstract "To ascertain the optimal dose of trimethaphan camsylate administered by intravenous (i.v.) bolus injection for the control of hypertension and tachycardia during electroconvulsive therapy (ECT).Prospective, double blind, within-subject study.Treating room of the psychiatric unit of the University Hospital at Stony Brook, NY.Patients undergoing ECT for major psychiatric illnesses.Fifteen ASA status I or II patients received in a random sequence placebo, or 5, 10, or 15 mg boluses of trimethaphan during their second to fifth treatments. Blood pressure (BP) and heart rate (HR) were recorded every 30 seconds by automated oscillometric recorder. Recordings taken before administration, during seizure, 5, and 20 minutes after seizure were examined. All doses ameliorated BP (systolic, diastolic, and mean), HR, and rate pressure product (RPP) increases during the seizure, compared with placebo. The group that received 15 mg exhibited smaller increases in RPP, i.e., 67.7% increase compared with 155.4%, 110.9%, and 98.7% increases for the placebo, 5, and 10 mg, respectively. The 10 mg and 15 mg doses caused a faster return to baseline than did the 5 mg dose or placebo. No rebound hypertension, prolonged hypotension, arrhythmias, or other side effects were noted. Trimethaphan did not alter seizure duration.Trimethaphan is safe, practical, and effective in the management of the hyperdynamic response to ECT. An i.v. bolus injection of 15 mg is more effective than 10 mg or 5 mg." @default.
- W2121626454 created "2016-06-24" @default.
- W2121626454 creator A5006299559 @default.
- W2121626454 creator A5011978910 @default.
- W2121626454 creator A5028691991 @default.
- W2121626454 creator A5041544620 @default.
- W2121626454 creator A5090443412 @default.
- W2121626454 date "1996-03-01" @default.
- W2121626454 modified "2023-09-23" @default.
- W2121626454 title "Trimethaphan (arfonad) control of hypertension and tachycardia during electroconvulsive therapy: A double-blind study" @default.
- W2121626454 cites W150890319 @default.
- W2121626454 cites W2005139941 @default.
- W2121626454 cites W2023827611 @default.
- W2121626454 cites W2035196377 @default.
- W2121626454 cites W2042371311 @default.
- W2121626454 cites W2043894988 @default.
- W2121626454 cites W2057279721 @default.
- W2121626454 cites W2091258421 @default.
- W2121626454 cites W2092328783 @default.
- W2121626454 cites W2116440408 @default.
- W2121626454 cites W2147172602 @default.
- W2121626454 cites W2407444159 @default.
- W2121626454 cites W2473267633 @default.
- W2121626454 doi "https://doi.org/10.1016/0952-8180(95)00192-1" @default.
- W2121626454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8695090" @default.
- W2121626454 hasPublicationYear "1996" @default.
- W2121626454 type Work @default.
- W2121626454 sameAs 2121626454 @default.
- W2121626454 citedByCount "15" @default.
- W2121626454 countsByYear W21216264542013 @default.
- W2121626454 countsByYear W21216264542021 @default.
- W2121626454 countsByYear W21216264542022 @default.
- W2121626454 crossrefType "journal-article" @default.
- W2121626454 hasAuthorship W2121626454A5006299559 @default.
- W2121626454 hasAuthorship W2121626454A5011978910 @default.
- W2121626454 hasAuthorship W2121626454A5028691991 @default.
- W2121626454 hasAuthorship W2121626454A5041544620 @default.
- W2121626454 hasAuthorship W2121626454A5090443412 @default.
- W2121626454 hasConcept C126322002 @default.
- W2121626454 hasConcept C142724271 @default.
- W2121626454 hasConcept C204787440 @default.
- W2121626454 hasConcept C27081682 @default.
- W2121626454 hasConcept C2777330709 @default.
- W2121626454 hasConcept C2777953023 @default.
- W2121626454 hasConcept C2780283014 @default.
- W2121626454 hasConcept C2910926394 @default.
- W2121626454 hasConcept C42219234 @default.
- W2121626454 hasConcept C43376680 @default.
- W2121626454 hasConcept C71924100 @default.
- W2121626454 hasConcept C84393581 @default.
- W2121626454 hasConceptScore W2121626454C126322002 @default.
- W2121626454 hasConceptScore W2121626454C142724271 @default.
- W2121626454 hasConceptScore W2121626454C204787440 @default.
- W2121626454 hasConceptScore W2121626454C27081682 @default.
- W2121626454 hasConceptScore W2121626454C2777330709 @default.
- W2121626454 hasConceptScore W2121626454C2777953023 @default.
- W2121626454 hasConceptScore W2121626454C2780283014 @default.
- W2121626454 hasConceptScore W2121626454C2910926394 @default.
- W2121626454 hasConceptScore W2121626454C42219234 @default.
- W2121626454 hasConceptScore W2121626454C43376680 @default.
- W2121626454 hasConceptScore W2121626454C71924100 @default.
- W2121626454 hasConceptScore W2121626454C84393581 @default.
- W2121626454 hasLocation W21216264541 @default.
- W2121626454 hasLocation W21216264542 @default.
- W2121626454 hasOpenAccess W2121626454 @default.
- W2121626454 hasPrimaryLocation W21216264541 @default.
- W2121626454 hasRelatedWork W1980725048 @default.
- W2121626454 hasRelatedWork W2020881001 @default.
- W2121626454 hasRelatedWork W2080670565 @default.
- W2121626454 hasRelatedWork W2121626454 @default.
- W2121626454 hasRelatedWork W2122930954 @default.
- W2121626454 hasRelatedWork W2142912509 @default.
- W2121626454 hasRelatedWork W2149750373 @default.
- W2121626454 hasRelatedWork W2376289066 @default.
- W2121626454 hasRelatedWork W2397907377 @default.
- W2121626454 hasRelatedWork W2407536295 @default.
- W2121626454 isParatext "false" @default.
- W2121626454 isRetracted "false" @default.
- W2121626454 magId "2121626454" @default.
- W2121626454 workType "article" @default.